More than 150 mutations in the sodium channel protein have been identified in patients with GEFS+ and SMEI. (A) Missense mutations of SCN1A identified in families with GEFS+ (14, 16, 17, 19, 21–25). (B) Truncation mutations of SCN1A identified in SMEI patients (18, 26, 27, 44, 47, 50, 53, 54, 79–84). (C) Missense mutations of SCN1A in patients with SMEI (red), intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC) (orange), and infantile spasms (purple) (18, 26, 27, 44, 47, 50, 53, 79–84). (D) Mutations of SCN2A in patients with benign familial neonatal-infantile seizures (BFNIS) (blue), GEFS+ (yellow), and SMEI (red) (29–32).